Daphne Quimi, VP Finance and Controller at AMICUS THERAPEUTICS INC (FOLD), bought 3,500 shares at $8.00 ($28K) on 2014-11-25, disclosed to the SEC on 2014-11-25.
Scheduled purchase ($28k) by VP Finance and Controller under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| FOLD | SELL | 2023-01-19 | $152K | — | Filing → |
| FOLD | SELL | 2022-09-06 | $50K | — | Filing → |
| FOLD | SELL | 2022-08-09 | $70K | — | Filing → |